Protein and Peptide Therapeutics Market, Global Outlook and Forecast 2024-2031

Report ID: 1658799 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Protein and Peptide Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Protein and Peptide Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Protein and Peptide Therapeutics Overall Market Size
    2.1 Global Protein and Peptide Therapeutics Market Size: 2021 VS 2028
    2.2 Global Protein and Peptide Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Protein and Peptide Therapeutics Players in Global Market
    3.2 Top Global Protein and Peptide Therapeutics Companies Ranked by Revenue
    3.3 Global Protein and Peptide Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Protein and Peptide Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Protein and Peptide Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Protein and Peptide Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Protein and Peptide Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Protein and Peptide Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Injection
        4.1.3 Oral
    4.2 By Type - Global Protein and Peptide Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Protein and Peptide Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Protein and Peptide Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Protein and Peptide Therapeutics Market Size, 2021 & 2028
        5.1.2 Cancer
        5.1.3 Metabolic Disorders
        5.1.4 Central Nervous System
        5.1.5 Other
    5.2 By Application - Global Protein and Peptide Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Protein and Peptide Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Protein and Peptide Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Protein and Peptide Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Protein and Peptide Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Protein and Peptide Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Protein and Peptide Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Protein and Peptide Therapeutics Revenue, 2017-2028
        6.3.2 US Protein and Peptide Therapeutics Market Size, 2017-2028
        6.3.3 Canada Protein and Peptide Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Protein and Peptide Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Protein and Peptide Therapeutics Revenue, 2017-2028
        6.4.2 Germany Protein and Peptide Therapeutics Market Size, 2017-2028
        6.4.3 France Protein and Peptide Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Protein and Peptide Therapeutics Market Size, 2017-2028
        6.4.5 Italy Protein and Peptide Therapeutics Market Size, 2017-2028
        6.4.6 Russia Protein and Peptide Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Protein and Peptide Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Protein and Peptide Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Protein and Peptide Therapeutics Revenue, 2017-2028
        6.5.2 China Protein and Peptide Therapeutics Market Size, 2017-2028
        6.5.3 Japan Protein and Peptide Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Protein and Peptide Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Protein and Peptide Therapeutics Market Size, 2017-2028
        6.5.6 India Protein and Peptide Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Protein and Peptide Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Protein and Peptide Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Protein and Peptide Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Protein and Peptide Therapeutics Market Size, 2017-2028
        6.7.3 Israel Protein and Peptide Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Protein and Peptide Therapeutics Market Size, 2017-2028
        6.7.5 UAE Protein and Peptide Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Protein and Peptide Therapeutics Major Product Offerings
        7.1.4 Sanofi Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Sanofi Key News
    7.2 Teva
        7.2.1 Teva Corporate Summary
        7.2.2 Teva Business Overview
        7.2.3 Teva Protein and Peptide Therapeutics Major Product Offerings
        7.2.4 Teva Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Teva Key News
    7.3 Novo Nordisk
        7.3.1 Novo Nordisk Corporate Summary
        7.3.2 Novo Nordisk Business Overview
        7.3.3 Novo Nordisk Protein and Peptide Therapeutics Major Product Offerings
        7.3.4 Novo Nordisk Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Novo Nordisk Key News
    7.4 Takeda
        7.4.1 Takeda Corporate Summary
        7.4.2 Takeda Business Overview
        7.4.3 Takeda Protein and Peptide Therapeutics Major Product Offerings
        7.4.4 Takeda Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Takeda Key News
    7.5 Eli Lilly
        7.5.1 Eli Lilly Corporate Summary
        7.5.2 Eli Lilly Business Overview
        7.5.3 Eli Lilly Protein and Peptide Therapeutics Major Product Offerings
        7.5.4 Eli Lilly Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Eli Lilly Key News
    7.6 AstraZeneca
        7.6.1 AstraZeneca Corporate Summary
        7.6.2 AstraZeneca Business Overview
        7.6.3 AstraZeneca Protein and Peptide Therapeutics Major Product Offerings
        7.6.4 AstraZeneca Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 AstraZeneca Key News
    7.7 Novartis
        7.7.1 Novartis Corporate Summary
        7.7.2 Novartis Business Overview
        7.7.3 Novartis Protein and Peptide Therapeutics Major Product Offerings
        7.7.4 Novartis Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Novartis Key News
    7.8 AbbVie
        7.8.1 AbbVie Corporate Summary
        7.8.2 AbbVie Business Overview
        7.8.3 AbbVie Protein and Peptide Therapeutics Major Product Offerings
        7.8.4 AbbVie Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 AbbVie Key News
    7.9 Ipsen
        7.9.1 Ipsen Corporate Summary
        7.9.2 Ipsen Business Overview
        7.9.3 Ipsen Protein and Peptide Therapeutics Major Product Offerings
        7.9.4 Ipsen Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Ipsen Key News
    7.10 Ferring
        7.10.1 Ferring Corporate Summary
        7.10.2 Ferring Business Overview
        7.10.3 Ferring Protein and Peptide Therapeutics Major Product Offerings
        7.10.4 Ferring Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 Ferring Key News
    7.11 Merck
        7.11.1 Merck Corporate Summary
        7.11.2 Merck Business Overview
        7.11.3 Merck Protein and Peptide Therapeutics Major Product Offerings
        7.11.4 Merck Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.11.5 Merck Key News
    7.12 The Medicines
        7.12.1 The Medicines Corporate Summary
        7.12.2 The Medicines Business Overview
        7.12.3 The Medicines Protein and Peptide Therapeutics Major Product Offerings
        7.12.4 The Medicines Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.12.5 The Medicines Key News
    7.13 J & J
        7.13.1 J & J Corporate Summary
        7.13.2 J & J Business Overview
        7.13.3 J & J Protein and Peptide Therapeutics Major Product Offerings
        7.13.4 J & J Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
        7.13.5 J & J Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Protein and Peptide Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Protein and Peptide Therapeutics Market Drivers in Global Market
    Table 3. Protein and Peptide Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Protein and Peptide Therapeutics in Global Market
    Table 5. Top Protein and Peptide Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Protein and Peptide Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Protein and Peptide Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Protein and Peptide Therapeutics Product Type
    Table 9. List of Global Tier 1 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Sanofi Corporate Summary
    Table 31. Sanofi Protein and Peptide Therapeutics Product Offerings
    Table 32. Sanofi Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Teva Corporate Summary
    Table 34. Teva Protein and Peptide Therapeutics Product Offerings
    Table 35. Teva Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Novo Nordisk Corporate Summary
    Table 37. Novo Nordisk Protein and Peptide Therapeutics Product Offerings
    Table 38. Novo Nordisk Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Takeda Corporate Summary
    Table 40. Takeda Protein and Peptide Therapeutics Product Offerings
    Table 41. Takeda Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. Eli Lilly Corporate Summary
    Table 43. Eli Lilly Protein and Peptide Therapeutics Product Offerings
    Table 44. Eli Lilly Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. AstraZeneca Corporate Summary
    Table 46. AstraZeneca Protein and Peptide Therapeutics Product Offerings
    Table 47. AstraZeneca Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis Corporate Summary
    Table 49. Novartis Protein and Peptide Therapeutics Product Offerings
    Table 50. Novartis Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. AbbVie Corporate Summary
    Table 52. AbbVie Protein and Peptide Therapeutics Product Offerings
    Table 53. AbbVie Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. Ipsen Corporate Summary
    Table 55. Ipsen Protein and Peptide Therapeutics Product Offerings
    Table 56. Ipsen Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 57. Ferring Corporate Summary
    Table 58. Ferring Protein and Peptide Therapeutics Product Offerings
    Table 59. Ferring Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 60. Merck Corporate Summary
    Table 61. Merck Protein and Peptide Therapeutics Product Offerings
    Table 62. Merck Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 63. The Medicines Corporate Summary
    Table 64. The Medicines Protein and Peptide Therapeutics Product Offerings
    Table 65. The Medicines Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 66. J & J Corporate Summary
    Table 67. J & J Protein and Peptide Therapeutics Product Offerings
    Table 68. J & J Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Protein and Peptide Therapeutics Segment by Type in 2021
    Figure 2. Protein and Peptide Therapeutics Segment by Application in 2021
    Figure 3. Global Protein and Peptide Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Protein and Peptide Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Protein and Peptide Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Protein and Peptide Therapeutics Revenue in 2021
    Figure 8. By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Sanofi Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Teva Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novo Nordisk Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Takeda Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Eli Lilly Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AstraZeneca Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AbbVie Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Ipsen Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Ferring Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Merck Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. The Medicines Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. J & J Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
Protein and Peptide Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Protein and Peptide Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Protein and Peptide Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports